High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$13.6M
$13,609,605
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Other
|
2026-04-01 | $433,930 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-04-01 | $94,655 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Chadwick Jeremy G
• COO
10b5-1 SellΔOwn -17.9%
2026-04-01
$1,156,511Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -17.9%
|
2026-04-01 | $1,156,511Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -11.1%
|
2026-03-31 | $648,882 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Other
|
2026-03-31 | $225,264 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Other
|
2026-03-25 | $732,908 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Chadwick Jeremy G
• COO
10b5-1 SellΔOwn -28.8%
2026-03-25
$1,984,554Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -28.8%
|
2026-03-25 | $1,984,554Large | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Chadwick Jeremy G
• COO
10b5-1 SellΔOwn -14.9%
2026-03-23
$1,746,134Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -14.9%
|
2026-03-23 | $1,746,134Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Other
|
2026-03-23 | $2,501,616Large | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Chadwick Jeremy G
• COO
10b5-1 SellΔOwn -40.9%
2026-03-23
$4,089,983Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -40.9%
|
2026-03-23 | $4,089,983Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -10.7%
|
2026-03-23 | $643,950 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-03-23 | $487,609 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-03-23 | $96,060 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Other
|
2026-03-11 | $870,000 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -14.0%
|
2026-03-11 | $930,207 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-03-11 | $144,955 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Chadwick Jeremy G
• COO
10b5-1 SellΔOwn -14.0%
2026-03-11
$1,070,511Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 SellΔOwn -14.0%
|
2026-03-11 | $1,070,511Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $171,518 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $33,095 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $31,012 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $98,648 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-02 | $99,251 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-02 | $48,175 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-02 | $33,896 | S | Form 4 |